Cargando…

Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.

Epidermal growth factor receptors (EGFr) were measured using a radioligand binding assay, in membrane preparations from 51 human non-small cell lung cancers and in normal tissue of the same patients. The binding characteristics of EGFr were similar in tumour and normal lung membranes (range of disso...

Descripción completa

Detalles Bibliográficos
Autores principales: Dittadi, R., Gion, M., Pagan, V., Brazzale, A., Del Maschio, O., Bargossi, A., Busetto, A., Bruscagnin, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977711/
https://www.ncbi.nlm.nih.gov/pubmed/1654986
_version_ 1782135320946409472
author Dittadi, R.
Gion, M.
Pagan, V.
Brazzale, A.
Del Maschio, O.
Bargossi, A.
Busetto, A.
Bruscagnin, G.
author_facet Dittadi, R.
Gion, M.
Pagan, V.
Brazzale, A.
Del Maschio, O.
Bargossi, A.
Busetto, A.
Bruscagnin, G.
author_sort Dittadi, R.
collection PubMed
description Epidermal growth factor receptors (EGFr) were measured using a radioligand binding assay, in membrane preparations from 51 human non-small cell lung cancers and in normal tissue of the same patients. The binding characteristics of EGFr were similar in tumour and normal lung membranes (range of dissociation constant of high affinity sites: 0.1-0.6 nM). However, the concentrations in tumours (median, 16.4 fmol mg-1 of protein; range, 1.5-176) were significantly higher than in normal tissues (median, 7.4 fmol mg-1 of protein; range, 1.9-13.4). The receptor levels in normal tissue were normally distributed. It was therefore possible to define a normal/pathologic cut-off level (12.9 fmol mg-1 of protein). In 57% of cases EGFr in cancer was higher than the cut-off. No relationships were found between receptor concentrations and positivity rates of EGFr and histology, stage, lymph node positivity and pT. A trend for a direct relation between receptor positivity and grading was found.
format Text
id pubmed-1977711
institution National Center for Biotechnology Information
language English
publishDate 1991
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19777112009-09-10 Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue. Dittadi, R. Gion, M. Pagan, V. Brazzale, A. Del Maschio, O. Bargossi, A. Busetto, A. Bruscagnin, G. Br J Cancer Research Article Epidermal growth factor receptors (EGFr) were measured using a radioligand binding assay, in membrane preparations from 51 human non-small cell lung cancers and in normal tissue of the same patients. The binding characteristics of EGFr were similar in tumour and normal lung membranes (range of dissociation constant of high affinity sites: 0.1-0.6 nM). However, the concentrations in tumours (median, 16.4 fmol mg-1 of protein; range, 1.5-176) were significantly higher than in normal tissues (median, 7.4 fmol mg-1 of protein; range, 1.9-13.4). The receptor levels in normal tissue were normally distributed. It was therefore possible to define a normal/pathologic cut-off level (12.9 fmol mg-1 of protein). In 57% of cases EGFr in cancer was higher than the cut-off. No relationships were found between receptor concentrations and positivity rates of EGFr and histology, stage, lymph node positivity and pT. A trend for a direct relation between receptor positivity and grading was found. Nature Publishing Group 1991-10 /pmc/articles/PMC1977711/ /pubmed/1654986 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Dittadi, R.
Gion, M.
Pagan, V.
Brazzale, A.
Del Maschio, O.
Bargossi, A.
Busetto, A.
Bruscagnin, G.
Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
title Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
title_full Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
title_fullStr Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
title_full_unstemmed Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
title_short Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
title_sort epidermal growth factor receptor in lung malignancies. comparison between cancer and normal tissue.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977711/
https://www.ncbi.nlm.nih.gov/pubmed/1654986
work_keys_str_mv AT dittadir epidermalgrowthfactorreceptorinlungmalignanciescomparisonbetweencancerandnormaltissue
AT gionm epidermalgrowthfactorreceptorinlungmalignanciescomparisonbetweencancerandnormaltissue
AT paganv epidermalgrowthfactorreceptorinlungmalignanciescomparisonbetweencancerandnormaltissue
AT brazzalea epidermalgrowthfactorreceptorinlungmalignanciescomparisonbetweencancerandnormaltissue
AT delmaschioo epidermalgrowthfactorreceptorinlungmalignanciescomparisonbetweencancerandnormaltissue
AT bargossia epidermalgrowthfactorreceptorinlungmalignanciescomparisonbetweencancerandnormaltissue
AT busettoa epidermalgrowthfactorreceptorinlungmalignanciescomparisonbetweencancerandnormaltissue
AT bruscagning epidermalgrowthfactorreceptorinlungmalignanciescomparisonbetweencancerandnormaltissue